Data / New clinical trials / Netherlands
New clinical trials in Netherlands: 1,234 since Nov 2024
The full list. New clinical trials with a site in Netherlands: 1,234 rows for $61.70, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 30 rows a month. The new rows come each week by email, $19 a month.
Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.
For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/netherlands, and every list with its row count and price is at https://specstream.ai/data/lists.json.
Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).
1,234 clinical studies with a site in Netherlands were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 502 have an industry sponsor and 929 are recruiting or about to. The newest, NCT07924371, was posted on November 9, 2026: AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective... (Hospital Universitari Vall d'Hebron Research Institute).
The request: Every new clinical trial with a site in Netherlands, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.
- 1,234New trials
- 502Industry sponsored
- 929Recruiting or not yet
- November 9, 2026Latest posted
Newest trials
The newest 100 of 1,234, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.
| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
|---|---|---|---|---|---|---|---|---|---|
| November 9, 2026 | NCT07924371 | AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational Study | Hospital Universitari Vall d'Hebron Research Institute | Observational | Recruiting | Stroke, Ischemic Stroke, Intracerebral Hemorrhage, Transient Ischemic Attack, Atrial Fibrillation | 10,000 | Belgium, Germany, Italy, Netherlands, Spain, Switzerland | clinicaltrials.gov |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany... | clinicaltrials.gov |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia... | clinicaltrials.gov |
| November 3, 2026 | NCT07912411 | Continuous Noninvasive Multimodal Neuromonitoring at the ICU After Cardiac Arrest | Maastricht University Medical Center | Observational | Enrolling by invitation | Post-cardiac Arrest Brain Injury | 100 | Netherlands | clinicaltrials.gov |
| November 2, 2026 | NCT07909382 | Multi-biomarkers in DEE | Istituto Giannina Gaslini | Observational | Recruiting | Developmental and Epileptic Encephalopathies (DEE) | 200 | Belgium, Denmark, France, Germany, Israel, Italy, Netherlands, Spain | clinicaltrials.gov |
| October 30, 2026 | NCT07908186 | Trauma-Related Attributions in Trauma Treatment: An Observational Study | Reinier van Arkel | Observational | Completed | PTSD | 112 | Netherlands | clinicaltrials.gov |
| October 30, 2026 | NCT07908108 | Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma... | Istituto Giannina Gaslini | Observational | Active not recruiting | Scleroderma | 272 | Argentina, Brazil, China, Croatia, Denmark, Egypt, Germany, Greece, India... | clinicaltrials.gov |
| October 29, 2026 | NCT07905508 | A Retrospective Cohort Study Evaluating Major Adverse Cardiovascular Events and Cardiovascular Outcomes in Adults With Atherosclerotic... | Sanofi | Observational | Completed | Atherosclerotic Cardiovascular Disease | 180,000 | Netherlands | clinicaltrials.gov |
| October 29, 2026 | NCT07905482 | The REVIVE-PEEP Trial: Positive End-expiratory Pressure Versus Sham Valve/Zero End-expiratory Pressure in Cardiopulmonary Resuscitation... | Jeroen van Eijk | Not applicable | Active not recruiting | Cardiac Arrest, Out-Of-Hospital | 3,200 | Netherlands | clinicaltrials.gov |
| October 29, 2026 | NCT07903987 | Assessment of the Value of FAPI and FDG-PET-CT in Diagnosis of Acute Phase Peyronie's Disease | University Medical Center Groningen | Phase 4 | Recruiting | Peyronie's Disease | 20 | Netherlands | clinicaltrials.gov |
| October 28, 2026 | NCT07901881 | The Effect of Theory-driven Physiotherapy on Physical Activity in Knee OA. | Mark van Loo | Not applicable | Not yet recruiting | Knee Osteoarthritis | 20 | Netherlands | clinicaltrials.gov |
| October 28, 2026 | NCT07899853 | In-situ vs Ex-situ Liver Preservation | Leiden University Medical Center | Not applicable | Recruiting | Liver Disease (Alcoholic or Not), Transplantation | 752 | Netherlands | clinicaltrials.gov |
| October 26, 2026 | NCT07895342 | Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma | Radboud University Medical Center | Not applicable | Not yet recruiting | Hepatocellular Carcinoma Non-Resectable | 16 | Netherlands | clinicaltrials.gov |
| October 23, 2026 | NCT07893184 | Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via Sternotomy | Maastricht University Medical Center | Not applicable | Enrolling by invitation | Prehabilitation, Cardiac Surgery, Risk Assesment, Aortic Valve, Coronary Artery Bypass Graft, Training | 24 | Netherlands | clinicaltrials.gov |
| October 23, 2026 | NCT07892976 | The CORE Platform Trial | Copenhagen Trial Unit, Center for Clinical Intervention Research | Not applicable | Not yet recruiting | Coronary Revascularization, Coronary Artery Disease | 15,000 | Belgium, Denmark, Netherlands | clinicaltrials.gov |
| October 21, 2026 | NCT07887256 | Flap Assessment With Regional Oximetry for Early Detection of Compromise in Free Flap Reconstructive Surgery - FLARE Study | Leiden University Medical Center | Observational | Not yet recruiting | Reconstructive Surgery, Flap Monitoring | 100 | Netherlands | clinicaltrials.gov |
| October 21, 2026 | NCT07886957 | AI-based Algorithm Development for Improved Diagnostics in the Intensive Care and Acute Stroke Setting Using Electroencephalography | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Observational | Recruiting | Hemorrhagic Stroke, Intracerebral, Subarachnoid Haemorrhage (SAH), Postanoxic Coma | 825 | Netherlands | clinicaltrials.gov |
| October 21, 2026 | NCT07886541 | VATS or Intrapleural Enzymatic Therapy for Patients With Empyema. | Amsterdam UMC | Phase 4 | Recruiting | Empyema, Pleural, Pleural Infections | 164 | Netherlands | clinicaltrials.gov |
| October 20, 2026 | NCT07883551 | AI Analysis of CT Scans to Classify Ovarian Tumours as Benign, Borderline or Malignant Before Surgery | Catharina Ziekenhuis Eindhoven | Observational | Not yet recruiting | Ovarian Cancer, Ovarian Tumor, Borderline Ovarian Tumor | 1,300 | Belgium, Netherlands | clinicaltrials.gov |
| October 20, 2026 | NCT07883252 | Prehospital Transfusion Outcomes in Traumatic Hemorrhage: a Prospective Cohort Study | Erasmus Medical Center | Observational | Not yet recruiting | Trauma Associated Hemorrhage | 750 | Netherlands | clinicaltrials.gov |
| October 20, 2026 | NCT07882290 | Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) Disease | Beyond Batten Disease Foundation | Phase 3 | Not yet recruiting | CLN3 | 27 | Denmark, France, Germany, Italy, Netherlands, Sweden, United Kingdom, United... | clinicaltrials.gov |
| October 19, 2026 | NCT07881224 | A Multiple-dose Study Investigating the Drug-drug Interaction Potential and QTc Effects of Fosmanogepix in Healthy Adult Subjects | Basilea Pharmaceutica | Phase 1 | Recruiting | Healthy Adult Participants | 42 | Netherlands | clinicaltrials.gov |
| October 14, 2026 | NCT07873931 | A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases | Bristol-Myers Squibb | Phase 1 | Not yet recruiting | Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies, Systemic... | 60 | Belgium, France, Germany, Netherlands, Poland, United States | clinicaltrials.gov |
| October 13, 2026 | NCT07872020 | SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY Trial | Erasmus Medical Center | Not applicable | Recruiting | Aortic Valve Stenosis and/or Insufficiency, Hypoattenuated Leaflet Thickening, Valve Expansion, Transcatheter Aortic... | 422 | Germany, Netherlands | clinicaltrials.gov |
| October 13, 2026 | NCT07871864 | Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse | Gustave Roussy, Cancer Campus, Grand Paris | Phase 3 | Recruiting | Osteosarcoma, Pediatric Osteosarcoma, Osteosarcoma in Children, Osteosarcoma in Adolescents and Young Adults... | 530 | Denmark, Finland, France, Italy, Netherlands, Poland, Spain, Sweden | clinicaltrials.gov |
| October 13, 2026 | NCT07870551 | The OXY-VENT Study | Jeroen van Eijk | Not applicable | Not yet recruiting | Cardiac Arrest (CA), Cardiopulmonary Resuscitation (CPR) | 515 | Netherlands | clinicaltrials.gov |
| October 9, 2026 | NCT07867886 | An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBM | Boston Scientific Corporation | Not applicable | Not yet recruiting | Recurrent Glioblastoma | 30 | France, Germany, Netherlands, Spain | clinicaltrials.gov |
| October 8, 2026 | NCT07866846 | Managing Pasireotide-associated Hyperglycaemia in Acromegaly With Ketogenic Diet | Leiden University Medical Center | Not applicable | Recruiting | Acromegaly Due to Pituitary Adenoma, Hyperglycemia, Ketogenic Diet, Standard Care Control | 30 | Netherlands | clinicaltrials.gov |
| October 8, 2026 | NCT07866547 | Off-line Adaptive Proton Therapy | University Medical Center Groningen | Observational | Not yet recruiting | Oropharyngeal Carcinoma | 100 | Netherlands | clinicaltrials.gov |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark... | clinicaltrials.gov |
| October 6, 2026 | NCT07860775 | Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma With Pirtobrutinib in Combination With Epcoritamab if the Disease... | Stichting Hemato-Oncologie voor Volwassenen Nederland | Phase 2 | Not yet recruiting | CLL / SLL | 70 | Denmark, Netherlands, Sweden | clinicaltrials.gov |
| September 30, 2026 | NCT07850206 | NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity | Institut National de la Santé Et de la Recherche Médicale, France | Not applicable | Not yet recruiting | Obesity (BMI>30), Immune Abnormalities, Low-grade Inflammation | 168 | France, Germany, Netherlands | clinicaltrials.gov |
| September 30, 2026 | NCT07848295 | A Study to Assess the Safety and Tolerability of BMS-986527 in Participants With Clear Cell Renal Cell Carcinoma (ccRCC) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | Phase 1 | Not yet recruiting | Clear Cell Renal Cell Carcinoma (ccRCC) | 112 | Belgium, France, Germany, Italy, Netherlands, Spain, United States | clinicaltrials.gov |
| September 29, 2026 | NCT07846046 | Endoscopic (EID) Versus Surgical (TAMIS) Local Excision for Early Stage Rectal Cancer | Amsterdam UMC, location VUmc | Not applicable | Not yet recruiting | Rectal Cancer Stage I | 246 | Netherlands | clinicaltrials.gov |
| September 29, 2026 | NCT07845838 | The Effect of Training on Oxidative Stress in Patients With kneeOA. | Mariette Boshuis | Not applicable | Recruiting | Knee Osteoarthritis, Oxidative Stress | 20 | Netherlands | clinicaltrials.gov |
| September 28, 2026 | NCT07843940 | A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35) | Boehringer Ingelheim | Phase 1/2 | Recruiting | Extensive-stage Small Cell Lung Carcinoma, Advanced Small Cell Lung Cancer | 55 | Australia, Belgium, China, France, Germany, Japan, Netherlands, Poland, Spain... | clinicaltrials.gov |
| September 25, 2026 | NCT07842380 | Effects of Just-In-Time Food Swap Recommendations | Tilburg University | Not applicable | Completed | Behavior: Healthy Food Choice | 607 | Netherlands | clinicaltrials.gov |
| September 25, 2026 | NCT07840924 | The CanISleepinMS Study: Effect of Cannabidiol (CBD) on Sleep Quality in Patients With Multiple Sclerosis | Wageningen University | Phase 2 | Completed | Sleep Quality, Multiple Sclerosis, Insomnia | 16 | Netherlands | clinicaltrials.gov |
| September 23, 2026 | NCT07837128 | PERMISSive Lung-protective Ventilation RCT | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Recruiting | Invasive Ventilation, Critical Illness, Intensive Care (ICU), Mechanical Ventilation | 926 | Netherlands | clinicaltrials.gov |
| September 22, 2026 | NCT07835256 | Effectiveness of a Combined e-Learning and Virtual Reality Training Program for Healthcare Providers in Rheumatology | Leiden University | Not applicable | Recruiting | Rheumatic Diseases | 936 | Netherlands | clinicaltrials.gov |
| September 21, 2026 | NCT07831057 | Temperature Optimization in Afebrile Septic PatienTs | Matt Harmon | Not applicable | Recruiting | Sepsis, Temperature | 50 | Netherlands | clinicaltrials.gov |
| September 17, 2026 | NCT07824050 | Analysis of Life-threatening ARrhythMias After Acute Coronary Syndrome | Catharina Ziekenhuis Eindhoven | Observational | Recruiting | Acute Coronary Syndromes (ACS), Ventricular Tachycardia (VT), Ventricular Fibrillation, Pulseless Electrical Activity... | 2,775 | Netherlands | clinicaltrials.gov |
| September 16, 2026 | NCT07822165 | A Migration-Focused Adaptation of EMDR for Psychological Distress Among Turkish Migrants | Derin Kubilay | Not applicable | Completed | Depression, Anxiety, Stress, Social Adaptation | 38 | Netherlands, Turkey (Türkiye) | clinicaltrials.gov |
| September 15, 2026 | NCT07819864 | Diaphragm Hibernation and Its Driving Factors in Mechanically Ventilated ICU Patients | Radboud University Medical Center | Observational | Not yet recruiting | Diaphragm Dysfunction, Weaning Invasive Mechanical Ventilation, Respiratory Failure, ICU | 112 | Netherlands | clinicaltrials.gov |
| September 14, 2026 | NCT07819227 | Optimizing Albuminuria Treatment in CKD With Finerenone and Semaglutide | University Medical Center Groningen | Phase 2 | Completed | Chronic Kidney Disease | 41 | Denmark, Italy, Netherlands, Spain | clinicaltrials.gov |
| September 11, 2026 | NCT07816458 | Alert-HF: Early Detection and Intervention on Atrial Fibrillation in Heart Failure Patients | Medisch Spectrum Twente | Phase 4 | Not yet recruiting | Heart Failure | 258 | Netherlands | clinicaltrials.gov |
| September 11, 2026 | NCT07815444 | Lipofilling in Operative Hand Fracture Treatment | Jeroen Bosch Ziekenhuis | Not applicable | Not yet recruiting | Adhesions, Hand Fractures, Tenolysis | 130 | Netherlands | clinicaltrials.gov |
| September 11, 2026 | NCT07815171 | Lattice vs Pentaspline Comparative Evaluation in Persistent AF | Mitera Hospital | Not applicable | Not yet recruiting | Persistent Atrial Fibrillation | 250 | France, Greece, Netherlands, Spain, Switzerland | clinicaltrials.gov |
| September 10, 2026 | NCT07812623 | A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes | Maxima Medical Center | Not applicable | Recruiting | Diabetes Mellitus, Diabetes Mellitus Type 2 | 30 | Netherlands | clinicaltrials.gov |
| September 10, 2026 | NCT07811349 | The DREAM-VR Study: Does a Virtual Reality Tool Help Dental Students Master Acute Medical Emergencies Better? | Denise van Diermen | Not applicable | Not yet recruiting | Competency, Confidence, Self, Medical Emergency Calls, Dentistry, Virtual Reality | 140 | Netherlands | clinicaltrials.gov |
| September 10, 2026 | NCT07811336 | Optimized AFO Care For Children With Cerebral Palsy. | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Not yet recruiting | Cerebral Palsy (CP) | 86 | Netherlands | clinicaltrials.gov |
| September 9, 2026 | NCT07811193 | A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With... | Vividion Therapeutics, Inc. | Phase 2 | Recruiting | Colorectal Adenocarcinoma | 140 | Argentina, Belgium, Brazil, China, France, Germany, Greece, Hong Kong, Italy... | clinicaltrials.gov |
| September 8, 2026 | NCT07808151 | Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer | Solstice Oncology, Inc. | Phase 2 | Recruiting | Colon Cancer | 100 | Belgium, Italy, Netherlands, Spain, United Kingdom, United States | clinicaltrials.gov |
| September 8, 2026 | NCT07808138 | RADICAL-IO: thRee Cycles of immunotherApy Without raDical Therapy In mediCALly InOperable Stage I Non-small Cell Lung Cancer | The Netherlands Cancer Institute | Phase 2 | Not yet recruiting | Non Small Cell Lung Cancer, Immunotherapy | 30 | Netherlands | clinicaltrials.gov |
| September 8, 2026 | NCT07807319 | Loose Seton Prior to Surgery for Single-tract Cryptoglandular Fistula vs no Seton | Proctos Kliniek | Not applicable | Recruiting | Cryptoglandular Perianal Fistula | 277 | Netherlands | clinicaltrials.gov |
| September 8, 2026 | NCT07806266 | EORTC Metastatic Breast Cancer Module Development | University of Leeds | Observational | Recruiting | Metastatic Beast Cancer | 568 | Belgium, Canada, France, Germany, India, Italy, Japan, Jordan, Netherlands... | clinicaltrials.gov |
| September 4, 2026 | NCT07805057 | Magnetic Brain Stimulation in Small Fiber Neuropathy | Maastricht University Medical Center | Not applicable | Recruiting | Small Fiber Neuropathy | 124 | Netherlands | clinicaltrials.gov |
| September 4, 2026 | NCT07804134 | Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in... | Medisch Spectrum Twente | Observational | Not yet recruiting | Psoriasis, Eczema/Atopic Dermatitis, Hidradenitis Suppurativa (HS) | 1,000 | Netherlands | clinicaltrials.gov |
| September 3, 2026 | NCT07803042 | Using a Digital Spacer for Inhaler Technique Education in Pediatric Asthma | University Medical Center Groningen | Not applicable | Not yet recruiting | Asthma (Diagnosis), Inhaler Technique, Pediatric Asthma | 12 | Netherlands | clinicaltrials.gov |
| September 3, 2026 | NCT07802678 | Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors | Sint Maartenskliniek | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 202 | Netherlands | clinicaltrials.gov |
| September 3, 2026 | NCT07801690 | Brachytherapy (Interventional Radiotherapy) for Squamous Cell Carcinomas of the Nasal Vestibule: Optimization of Dose and Technique | Radboud University Medical Center | Observational | Not yet recruiting | Carcinoma Nasal Vestibule | 300 | Netherlands | clinicaltrials.gov |
| September 2, 2026 | NCT07799298 | Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Not yet recruiting | Pancreatic Cancer, Pancreatectomy, Adenocarcinoma Pancreas | 360 | Netherlands | clinicaltrials.gov |
| September 1, 2026 | NCT07798674 | TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic Ataxias | Heidelberg University | Observational | Recruiting | Hereditary Spastic Paraplegia, Spastic Ataxia | 4,000 | Austria, Czechia, France, Germany, Ireland, Italy, Netherlands, Poland, Spain | clinicaltrials.gov |
| September 1, 2026 | NCT07797855 | A Study to See How Safe a New Medicine (NNC0705-0002) is in Healthy People | Novo Nordisk A/S | Phase 1 | Recruiting | Healthy Volunteers, Cardiometabolic Diseases | 112 | Netherlands | clinicaltrials.gov |
| September 1, 2026 | NCT07796594 | Integration of Whole-Genome Sequencing PrOfiles and ImmuNe StATus in Cancer | Amsterdam UMC, location VUmc | Not applicable | Active not recruiting | Melanoma, Pancreas Cancer | 180 | Netherlands | clinicaltrials.gov |
| August 31, 2026 | NCT07795216 | Affordable, Tailored Physical Therapy for Financially Vulnerable People With Trauma-related Injuries (AFTER-TRAUMA) | Radboud University Medical Center | Observational | Recruiting | Quality of Life, PROMs | 153 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07793526 | Back on Track: Evaluation of an Occupational Reintegration Protocol for Employees With Musculoskeletal Disorders | Amsterdam UMC, location VUmc | Observational | Recruiting | Musculoskeletal Disorders (MSDs) | 140 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07792694 | Predict Arrhythmia Risk Using Intelligent Software | Catharina Ziekenhuis Eindhoven | Observational | Recruiting | Cardiac Arrhythmias, Acute Myocardial Infarction (AMI), Ventricular Tachycardia (VT), Ventricular Fibrillation | 3,000 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07792538 | Psilocybin-Assisted Psychotherapy for Veterans With PTSD | ARQ National Psychotrauma Centre | Phase 2 | Not yet recruiting | Posttraumatic Stress Disorder (PTSD) | 12 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07792486 | Percutaneous Drainage Versus EUS-guided Gallbladder Drainage in Poor Surgical Patients With Cholecystitis | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Not yet recruiting | Cholecystitis, Acute | 212 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07792317 | Hypothermic Machine Perfusion With Omnisol of Deceased Donor Kidneys Prior to Transplantation | Vivalyx GmbH | Not applicable | Recruiting | Kidney Transplant, Kidney Failure, Renal and Urinary Tract Therapeutic Procedures, End Stage Renal Disease (ESRD) | 15 | Netherlands | clinicaltrials.gov |
| August 28, 2026 | NCT07789483 | An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy | Alexion Pharmaceuticals, Inc. | Phase 3 | Not yet recruiting | Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 1,180 | Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia... | clinicaltrials.gov |
| August 27, 2026 | NCT07789015 | A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Idiopathic Inflammatory Myopathies | 270 | Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia... | clinicaltrials.gov |
| August 26, 2026 | NCT07786883 | Dialectic Behaviour Therapy (DBT) for People With Autism: A Multiple Baseline Single Case Design | GGZ Friesland | Not applicable | Recruiting | Autism Spectrum Disorder | 6 | Netherlands | clinicaltrials.gov |
| August 25, 2026 | NCT07785180 | A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy | Stemline Therapeutics, Inc. | Observational | Recruiting | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | 140 | Denmark, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain... | clinicaltrials.gov |
| August 24, 2026 | NCT07782164 | Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study) | Amsterdam UMC, location VUmc | Observational | Recruiting | Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer... | 27 | Netherlands | clinicaltrials.gov |
| August 24, 2026 | NCT07781722 | Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis | Amsterdam UMC, location VUmc | Phase 4 | Not yet recruiting | Post-ERCP Pancreatitis | 520 | Netherlands | clinicaltrials.gov |
| August 21, 2026 | NCT07779213 | Detection of Atrial Fibrillation Using PPG From Smartphone Cameras | Happitech BV | Observational | Recruiting | Atrial Fibrillation (AF) | 554 | Netherlands, United States | clinicaltrials.gov |
| August 20, 2026 | NCT07777133 | A Study to Evaluate the Metabolism, the Routes and Extent of Elimination, and Drug Levels of [14C]Navlimetostat (BMS-986504) in Healthy... | Bristol-Myers Squibb | Phase 1 | Recruiting | Healthy Female Participants | 6 | Netherlands, United States | clinicaltrials.gov |
| August 20, 2026 | NCT07775872 | Prospective Natural History Study of POLG Disease | The POLG Foundation | Observational | Recruiting | PolG, Primary Mitochondrial Myopathy | 300 | Australia, Denmark, Finland, Netherlands, Norway, Spain, Sweden, United... | clinicaltrials.gov |
| August 19, 2026 | NCT07774546 | Peanut Butter and Brain Health | Penn State University | Not applicable | Not yet recruiting | Healthy Aging, Middle-aged and Older Adults | 45 | Netherlands | clinicaltrials.gov |
| August 19, 2026 | NCT07773545 | The Effect of Visual Patient Education on Helmet Use Behaviour in Elderly Patients After a Bicycle, E-bike, or Moped Accident | Erasmus Medical Center | Not applicable | Active not recruiting | Helmet Use, Cyclists, Video Information | 228 | Netherlands | clinicaltrials.gov |
| August 19, 2026 | NCT07773272 | Cardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome | Zuyderland Medisch Centrum | Observational | Recruiting | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Hypercholerolemia, Hypertension... | 1,215 | Netherlands | clinicaltrials.gov |
| August 18, 2026 | NCT07771465 | A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Kardigan, Inc. | Phase 3 | Recruiting | Symptomatic Genetic Dilated Cardiomyopathy (DCM) | 332 | Belgium, Denmark, France, Hungary, Italy, Netherlands, Poland, Spain, Sweden... | clinicaltrials.gov |
| August 18, 2026 | NCT07771439 | A Study to Investigate the Efficacy and Safety of Belumosudil Compared With Best Available Therapy in Participants Aged 12 Years or Older... | Sanofi | Phase 3 | Recruiting | Chronic Graft Versus Host Disease | 356 | Netherlands, Spain | clinicaltrials.gov |
| August 18, 2026 | NCT07770841 | Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight | Novo Nordisk A/S | Phase 3 | Recruiting | Overweight, Obesity | 450 | Belgium, Bulgaria, Denmark, France, Greece, Netherlands, Poland, Spain, Sweden... | clinicaltrials.gov |
| August 14, 2026 | NCT07765303 | Skin Type Determination Using Image Artificial Intelligence | Region Skane | Observational | Recruiting | Skin Ageing, Skin | 1,500 | Australia, Brazil, Chile, China, Denmark, Malawi, Netherlands, Spain, Sri... | clinicaltrials.gov |
| August 13, 2026 | NCT07764263 | Contextualizing Care for Patients With a Serious Illness | Radboud University Medical Center | Not applicable | Completed | Palliative Care | 81 | Netherlands | clinicaltrials.gov |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia... | clinicaltrials.gov |
| August 12, 2026 | NCT07760480 | Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone... | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 4 | Recruiting | Lupus Nephritis, Systemic Lupus Erythematosus (SLE) | 55 | Netherlands | clinicaltrials.gov |
| August 11, 2026 | NCT07757087 | A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity... | Novo Nordisk A/S | Phase 1 | Recruiting | Overweight, Obesity | 120 | Denmark, Netherlands | clinicaltrials.gov |
| August 7, 2026 | NCT07752225 | Long-term Effects of Avocado Consumption on Health in Pre-diabetic Individuals | Maastricht University Medical Center | Not applicable | Not yet recruiting | Prediabetes, Brain Insulin Sensitivity, Cerebral Blood Flow, Satiety and Food Intake, Food Reward, Brain Health... | 34 | Netherlands | clinicaltrials.gov |
| August 4, 2026 | NCT07744152 | A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours) | Boehringer Ingelheim | Phase 1 | Recruiting | Solid Tumours | 137 | Belgium, China, Germany, Netherlands, Spain | clinicaltrials.gov |
| August 4, 2026 | NCT07743762 | Percutaneous Versus EUS-guided Drainage of Symptomatic Fluid Collections After Left Pancreatectomy | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Not applicable | Not yet recruiting | Symptomatic Fluid Collection(s) | 96 | Netherlands | clinicaltrials.gov |
| August 3, 2026 | NCT07742735 | A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome... | VectivBio AG | Phase 3 | Recruiting | Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF) | 124 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark... | clinicaltrials.gov |
| August 3, 2026 | NCT07742319 | How Differences in the Composition of Microorganisms in the Soil Affect the Microorganisms in the Human Gut, Through the Vegetables That... | Leiden University Medical Center | Not applicable | Not yet recruiting | Pilot Study | 10 | Netherlands | clinicaltrials.gov |
| July 30, 2026 | NCT07737743 | A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease | Novartis Pharmaceuticals | Phase 2 | Recruiting | Sjögren's Disease | 344 | Australia, Canada, China, Colombia, France, Hungary, Israel, Netherlands... | clinicaltrials.gov |
| July 29, 2026 | NCT07734753 | Impact of Alirocumab on Cardiovascular Events in Participants With Atherosclerotic Cardiovascular Disease But Without Prior Ischemic Events | Sanofi | Observational | Completed | Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events | 4,006 | Netherlands | clinicaltrials.gov |
| July 29, 2026 | NCT07733089 | A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People With Plaque Psoriasis Over an 8-week Treatment Period | Zealand Pharma | Phase 1 | Recruiting | Plaque Psoriasis | 32 | Netherlands | clinicaltrials.gov |
| July 28, 2026 | NCT07731490 | Early Detection and IntervenTion in Heart Failure | University Hospital, Basel, Switzerland | Not applicable | Recruiting | Heart Failure (HF) | 18,000 | Austria, Bulgaria, Germany, Italy, Netherlands, South Korea, Spain... | clinicaltrials.gov |
Sponsors posting most
| Sponsor | New trials | Latest |
|---|---|---|
| Erasmus Medical Center | 80 | October 20, 2026 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 61 | October 21, 2026 |
| University Medical Center Groningen | 57 | October 29, 2026 |
| Radboud University Medical Center | 49 | October 26, 2026 |
| Maastricht University Medical Center | 42 | November 3, 2026 |
| Leiden University Medical Center | 34 | October 28, 2026 |
| Merck Sharp & Dohme LLC | 30 | June 5, 2026 |
| Boehringer Ingelheim | 26 | November 4, 2026 |
| AstraZeneca | 24 | August 12, 2026 |
| Novartis Pharmaceuticals | 24 | July 30, 2026 |
| Sanofi | 21 | October 29, 2026 |
| UMC Utrecht | 21 | July 14, 2026 |
| The Netherlands Cancer Institute | 20 | September 8, 2026 |
| Eli Lilly and Company | 20 | May 29, 2026 |
| Amsterdam UMC, location VUmc | 17 | September 29, 2026 |
| Novo Nordisk A/S | 16 | November 5, 2026 |
| Wageningen University | 15 | September 25, 2026 |
| Hoffmann-La Roche | 15 | March 27, 2026 |
| Bristol-Myers Squibb | 14 | October 14, 2026 |
| Janssen Research & Development, LLC | 13 | June 24, 2026 |
Conditions
| Condition group | New trials | Latest |
|---|---|---|
| Obesity | 37 | November 5, 2026 |
| Neoplasms | 35 | July 27, 2026 |
| Carcinoma, Non-Small-Cell Lung | 31 | September 8, 2026 |
| Heart Failure | 29 | September 11, 2026 |
| Prostatic Neoplasms | 24 | August 24, 2026 |
| Overweight | 22 | August 18, 2026 |
| Colorectal Neoplasms | 21 | August 24, 2026 |
| Atrial Fibrillation | 20 | November 9, 2026 |
| Breast Neoplasms | 20 | July 14, 2026 |
| Lung Neoplasms | 18 | August 24, 2026 |
| Cardiovascular Diseases | 18 | July 23, 2026 |
| Alzheimer Disease | 16 | July 2, 2026 |
| Renal Insufficiency, Chronic | 15 | September 14, 2026 |
| Atherosclerosis | 14 | October 29, 2026 |
| Motor Activity | 14 | October 28, 2026 |
| Coronary Artery Disease | 14 | October 23, 2026 |
| Colitis, Ulcerative | 14 | June 15, 2026 |
| Diabetes Mellitus, Type 2 | 13 | September 10, 2026 |
| Amyotrophic Lateral Sclerosis | 12 | June 29, 2026 |
| Crohn Disease | 12 | June 15, 2026 |
| Pulmonary Disease, Chronic Obstructive | 12 | April 29, 2026 |
| Hypertension | 11 | November 5, 2026 |
| Hidradenitis Suppurativa | 11 | September 4, 2026 |
| Melanoma | 11 | September 1, 2026 |
| Multiple Myeloma | 11 | July 27, 2026 |
By phase
| Phase | New trials | Latest |
|---|---|---|
| Not applicable | 371 | October 29, 2026 |
| Observational | 301 | November 9, 2026 |
| Phase 3 | 254 | November 5, 2026 |
| Phase 2 | 123 | October 6, 2026 |
| Phase 1 | 84 | October 19, 2026 |
| Phase 1/2 | 41 | September 28, 2026 |
| Phase 4 | 31 | October 29, 2026 |
| Phase 2/3 | 25 | May 26, 2026 |
| Early phase 1 | 4 | December 19, 2025 |
Where the register publishes
U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.